INHIBITION OF HUMAN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA BY A MONOCLONAL-ANTIBODY IN XENOGRAFT MODELS

被引:10
|
作者
ZHU, ZP
GHOSE, T
HOSKIN, D
LEE, CLY
FERNANDEZ, LA
ROWDEN, G
LEE, SHS
机构
[1] DALHOUSIE UNIV,DEPT PATHOL,HALIFAX B3H 4H7,NS,CANADA
[2] DALHOUSIE UNIV,DEPT MICROBIOL & IMMUNOL,HALIFAX B3H 4H7,NS,CANADA
[3] DALHOUSIE UNIV,DEPT MED,HALIFAX B3H 4H7,NS,CANADA
关键词
D O I
10.1002/ijc.2910560326
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To establish xenograft models of human B-cell chronic lymphocytic leukemia (CLL), we inoculated 5 x 10(6) D-10-1 cells, a subline of Epstein-Barr virus (EBV)-transformed human B-cell CLL with a marker chromosomal anomaly, into SCID or irradiated nude mice by the intravenous (i.v.) or intraperitoneal (i.p.) route. All i.p. tumor-inoculated mice developed rapidly progressive, lethal ascites tumor, and 100% of i.v. tumor-inoculated mice developed disseminated CLL. All mice died of tumor within 8 weeks of tumor inoculation. Tumor-inoculated SCID mice died earlier with wider tumor dissemination than the tumor-inoculated nude mice. All the tumor-inoculated SCID mice died earlier with wider tumor dissemination than the tumor-inoculated nude mice. All the tumor-inoculated mice had histologically confirmed metastases in lymph nodes, and most of them also had metastases in one or more internal organs. Cytogenetic analysis confirmed the origin of these tumors from the xeno-grafted D-10-1 cells. The D-10-1 cells harvested from the xenografts did not differ from the parent D-10-1 cells harvested from the xenografts did not differ from the parent D-10-1 cells as regards (1) reactivity with 2 monoclonal antigens; (ii) rate of proliferation in vitro; and (iii) sensitivity to the 2 chemotherapeutic agents, methotrexate and adriamycin. Administration of 50 mu g/mouse of DaI B02, and IgG(1) (K) MAB directed against surface-associated antigens of human B-cell CLL, significantly prolonged the survival of D-10-1- inoculated nude and SCID mice. The MAb was more effective in D-10-1-inoculated nude mice than in SCID mice. In all the D-10-1 xenograft models, the effectiveness of DaI BO2 decreased with higher tumor load but increased with the amount of MAb injected. DaI BO2 F(ab)'2 fragment failed to demonstrate any anti-tumor activity in D-10-1-inoculated nude mice. In vitro assays revealed that DaI BO2 had no direct inhibitory effect on D-10-1 cells, but could be cytotoxic towards D-10-1 cells in the presence of splenic cells or peritoneal macrophages from nude and SCID mice, or togeher with rabbit complement. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 50 条
  • [1] A NOVEL MONOCLONAL-ANTIBODY RECOGNIZING HUMAN THYMOCYTES AND B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS
    TASSONE, P
    BONELLI, P
    TUCCILLO, F
    BOND, HM
    TURCO, MC
    MORRONE, G
    CECCO, L
    CERRA, M
    VENUTA, S
    IMMUNOLOGY LETTERS, 1994, 39 (02) : 137 - 146
  • [2] CHARACTERIZATION OF B-CELL TYPE CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS BY SURFACE-MARKERS AND A MONOCLONAL-ANTIBODY
    KOZINER, B
    GEBHARD, D
    DENNY, T
    EVANS, RL
    AMERICAN JOURNAL OF MEDICINE, 1982, 73 (06): : 802 - 807
  • [3] A NOVEL MONOCLONAL-ANTIBODY RECOGNIZING HUMAN THYMOCYTES AND B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS (VOL 39, PG 137, 1994)
    TASSONE, P
    BONELLI, P
    TUCCILLO, F
    BOND, HM
    TURCO, MC
    MORRONE, G
    CECCO, L
    CERRA, M
    VENUTA, S
    IMMUNOLOGY LETTERS, 1994, 40 (01) : 81 - 81
  • [4] CHARACTERIZATION OF B-CELL TYPE CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) CELLS BY SURFACE-MARKERS AND A MONOCLONAL-ANTIBODY
    KOZINER, B
    GERBHARD, D
    EVANS, R
    GOOD, RA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 305 - 305
  • [5] MONOCLONAL-ANTIBODY ASSOCIATED WITH A LYMPHOCYTE SUBPOPULATION IN CHRONIC LYMPHOCYTIC-LEUKEMIA
    PRICE, GB
    BENZING, K
    STEWART, S
    GROVER, J
    IMMUNOLOGY LETTERS, 1985, 9 (01) : 9 - 14
  • [6] EFFECTS OF MONOCLONAL-ANTIBODY THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA
    FOON, KA
    SCHROFF, RW
    BUNN, PA
    MAYER, D
    ABRAMS, PG
    FER, M
    OCHS, J
    BOTTINO, GC
    SHERWIN, SA
    CARLO, DJ
    HERBERMAN, RB
    OLDHAM, RK
    BLOOD, 1984, 64 (05) : 1085 - 1093
  • [7] T-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - REPORT OF A CASE STUDIED WITH MONOCLONAL-ANTIBODY
    AISENBERG, AC
    WILKES, BM
    HARRIS, NL
    KOH, HK
    AMERICAN JOURNAL OF MEDICINE, 1982, 72 (04): : 695 - 699
  • [8] B-CELL DEFECT IN CHRONIC LYMPHOCYTIC-LEUKEMIA
    LAMBERSON, H
    DAVEY, F
    ZAMKOFF, K
    SCHRECK, C
    KUREC, A
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 1087 - 1087
  • [9] MURINE MONOCLONAL-ANTIBODY THERAPY IN 2 PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA
    DILLMAN, RO
    SHAWLER, DL
    SOBOL, RE
    COLLINS, HA
    BEAUREGARD, JC
    WORMSLEY, SB
    ROYSTON, I
    BLOOD, 1982, 59 (05) : 1036 - 1045
  • [10] CYTOKINES IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    FOA, R
    TOS, AG
    DICELLE, PF
    CARBONE, A
    MARCHIS, D
    VISCHIA, F
    CIGNETTI, A
    GUARINI, A
    LEUKEMIA & LYMPHOMA, 1991, 5 : 7 - 11